SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue for the June 2023 quarter is pegged at Rs. 14790.00 millions, about 13.41% up against Rs. 13041.20 millions recorded during the year-ago period.A comparatively good net profit growth of 41.14% to Rs. 2902.40 millions was reported for the quarter ended June 2023 compared to Rs. 2056.40 millions of previous same quarter.Operating profit for the quarter ended June 2023 rose to 4110.00 millions as compared to 2967.60 millions of corresponding quarter ended June 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 14790.00 13041.20 13.41 14790.00 13041.20 13.41 53487.30 49133.20 8.86
Other Income 560.00 266.10 110.45 560.00 266.10 110.45 1541.50 831.60 85.37
PBIDT 4110.00 2967.60 38.50 4110.00 2967.60 38.50 13597.80 11649.30 16.73
Interest 33.40 42.20 -20.85 33.40 42.20 -20.85 159.90 191.00 -16.28
PBDT 4076.60 2925.40 39.35 4076.60 2925.40 39.35 13437.90 11458.30 17.28
Depreciation 171.70 173.50 -1.04 171.70 173.50 -1.04 699.70 661.00 5.85
PBT 3904.90 2751.90 41.90 3904.90 2751.90 41.90 12738.20 10797.30 17.98
TAX 1002.50 695.50 44.14 1002.50 695.50 44.14 3244.10 2810.30 15.44
Deferred Tax -17.60 -12.20 44.26 -17.60 -12.20 44.26 -11.90 -1.30 815.38
PAT 2902.40 2056.40 41.14 2902.40 2056.40 41.14 9494.10 7987.00 18.87
Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00
PBIDTM(%) 27.79 22.76 22.12 27.79 22.76 22.12 25.42 23.71 7.22

Abbott India Share Price

25797.15 -65.00 (-0.25%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×